- About Us
- Nano-Social Network
- Nano Consulting
- My Account
December 4th, 2007
Consumer advocates and the biotechnology industry yesterday hailed a report on the Food and Drug Administration that outlines devastating inefficiencies at the agency and echoes what other groups have been complaining about for years.
Without the proper technology, the agency can't keep up with developments in emerging technologies such as nanotechnology or wireless health care, he said.
The report includes a recommendation for implementing an organizational and process structure, called an incubator for innovation, that supports regulatory work while bolstering internal science.
|Related News Press|
Biosensors: Distance makes the signal grow stronger March 1st, 2017
Smart multi-layered magnetic material acts as an electric switch: New study reveals characteristic of islands of magnetic metals between vacuum gaps, displaying tunnelling electric current March 1st, 2017
NovAliX Turns to High-Resolution Cryo-Transmission Electron Microscopy for Pre-Clinical Drug Discovery Research: Thermo Fisher Scientificís Cryo-TEM provides critical information for small molecule and biologic drug discovery February 28th, 2017